Log In
BCIQ
Print this Print this
 

ISV-102

  Manage Alerts
Collapse Summary General Information
Company Sun Pharmaceutical Industries Ltd.
DescriptionTetracycline-based ophthalmic solution formulated in DuraSite
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPreclinical
Standard IndicationBacterial infection
Indication DetailsTreat ocular infections
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

2

$71.5M

$48.0M

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

11/03/2015

$48.0M

$48.0M

0

06/08/2015

$23.5M

0

0

Get a free BioCentury trial today